Bio-Rad Labs (BIO) Reports Q4 EPS of $1.34
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $376.41 -1.57%
EPS Growth %: -1.3%
Financial Fact:
Income before income taxes: 26.86M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -1.3%
Financial Fact:
Income before income taxes: 26.86M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.34, may not compare to the analyst estimate of $1.18. Revenue for the quarter came in at $598.2 million versus the consensus estimate of $593.41 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
